Percutaneous Mechanical Thrombectomy Using Rotarex® S Device in Acute Limb Ischemia in Infrainguinal Occlusions

Table 6

Comparison of our data to historical clinical trials.

	Mortality at 30 days	Amputation rate	Success of revascularization
Rochester trial	16%	18%	70%
STILE trial	4%	5%	82%
TOPAS trial	5%	2%	80%
Our study^4	0.7%	2%	90.5% (68.7% + 21.8%)

thrombectomy as first-line treatment combined with overnight fibrinolysis.